ECCMID 2021

Hur tar hälso- och sjukvårdspersonal enklast del av symposier från årets ECCMID-kongress?

Jo, genom att delta i the Nordic Journey ECCMID Digest by Pfizer! Resan sker på engelska då både finsk, norsk och svensk hälso- och sjukvårdspersonal deltar. Läs mer nedan.

ECCMID Congress Journey

Receive carefully curated congress summaries
TOPICS IN FOCUS:
AMR anti microbial resistance, Vaccine hesitancy, Pneumococcal disease, mRNA and pneumococcal vaccines

The Journey will culminate in a 1 hour virtual meeting on respiratory infections on the 1st of December at 3 different timeslots: 12.00, 14.00 or 19.00. The meeting will enable sharing the latest insights and Nordic perspectives from the ECCMID 2021.

A warm welcome to join the journey!


MEETING AGENDA:

  • Jonas Ahl, MD PhD: Pneumococcal disease and vaccines – Why, When and Who?
  • Juhani Knuuti, Professor: Tackling disinformation in the digital age – How to make an impact with your own expertise?
  • Tone Tønjum, Professor: To the next level: What is the link between molecular decoration and antimicrobial resistance?

Meet the experts Q&A session

You are warmly welcomed to Join the Nordic Journey, the ECCMID Digest by Pfizer!
Press button above to register.

ANTIMICROBIAL STEWARDSHIP AND INFECTION PREVENTION — KEY TAKEAWAYS FROM ECCMID 2021


Antimicrobial resistance and its management via antimicrobial stewardship, and infection prevention and control measures were among the central topics of the ECCMID 2021. This article summarizes the main points discussed in the session “How to implement effective antimicrobial stewardship linked to infection prevention?”.

Read more

WHO FIGHTS THE SPREAD OF MISINFORMATION? ANSWERING THREE BURNING QUESTIONS SURROUNDING THE COVID-19 INFODEMIC. QUESTION #1: WHAT IS AN INFODEMIC AND HOW IS THE WHO FIGHTING IT?


The first part of a series summarizing The ECCMID 2021 seminar “Ethics and conspiracy regarding vaccines” takes a look at the infodemic management strategy of the WHO. Tim Nguyen highlighted how the social listening approach allows the WHO to quickly respond to trending misinformation in social media in his presentation “WHO strategy concerning the COVID-19 infodemic”.

Read more

WHO FIGHTS THE SPREAD OF MISINFORMATION? ANSWERING THREE BURNING QUESTIONS SURROUNDING THE COVID-19 INFODEMIC. QUESTION #2 WHO AND WHAT ARE THE DRIVERS BEHIND THE SUCCESS OF THE ANTI-VACCINE RHETORIC?    


The second part of the series summarising the ECCMID 2021 seminar “Ethics and conspiracy regarding vaccines” focuses on social media as an anti-vaccination communication platform. Federico Germani summarized research comparing the behaviour of pro-vaccine and anti-vaccine supporters in social media and revealed who the “superspreaders” of the anti-vaccination message really are in his presentation "The anti-vaccination infodemic on social media”.

Read more

WHO FIGHTS THE SPREAD OF MISINFORMATION? ANSWERING THREE BURNING QUESTIONS SURROUNDING THE COVID-19 INFODEMIC. QUESTION #3: INFOVEILLANCE, CENSORSHIP AND BEHAVIORAL MANIPULATION — WHAT ARE THE ETHICAL IMPLICATIONS OF INFODEMIC MANAGEMENT APPROACHES?    


The third part of the series summarizing the ECCMID 2021 seminar “Ethics and conspiracy regarding vaccines” dives into the ethics of infodemic response. Nikola Biller-Andorno explained how the most effective approaches in infodemic management may also be the most controversial ones in her presentation “Antivax in social media: an ethical analysis”.

Read more

POLYSACCHARIDE VS CONJUGATE VACCINES — HISTORY AND DIFFERENCES  

The Pfizer symposium “Revising the paradigm: the importance of adult vaccination against respiratory diseases” at ECCMID 2021 discussed the prevention of pneumococcal disease in adults. Peter Paradiso elucidated the history and differences of polysaccharide and conjugate vaccines in his presentation “Pneumococcal conjugate vaccination for adults: need for expanded valent conjugate vaccines”.

Read more

THE CHALLENGES OF EVALUATING THE BURDEN OF PNEUMOCOCCAL PNEUMONIA

Continuing the theme of pneumococcal disease at the Pfizer symposium “Revising the paradigm: the importance of adult vaccination against respiratory diseases” at ECCMID 2021Antoni Torres highlighted current challenges in diagnosing and preventing pneumococcal pneumonia in the adult population in his presentation “Assessing the burden of pneumococcal pneumonia in adults”.

Read more

RNA-BASED THERAPIES: BUILDING UPON PREVIOUS BREAKTHROUGHS

The second theme at the Pfizer symposium “Revising the paradigm: the importance of adult vaccination against respiratory diseases” at ECCMID 2021 was the use of RNA-based therapies. Özlem Türeci discussed mRNA as a therapeutic agent and the technology that enables mRNA engineering for different applications in her presentation “mRNA Vaccines: The Accelerated Development of a COVID-19 Vaccine Including Clinical Development and Early Data on Effectiveness”.

Read more

HOW DO mRNA VACCINES WORK?

In the Pfizer symposium “Revising the Paradigm: The Importance of Adult Vaccination Against Respiratory Diseases” at ECCMID 2021, Özlem Türeci discussed mRNA as a therapeutic agent and the mode of action of mRNA vaccines in her presentation “mRNA Vaccines: The Accelerated Development of a COVID-19 Vaccine Including Clinical Development and Early Data on Effectiveness”.
 

Read more

Watch the symposium here

PP-PNA-SWE-0384 okt 2021